Expression and Correlation of HER2/P53/VEGF in Marjolin's Ulcer

被引:0
作者
Xia, Chen [1 ,2 ]
Chu, Zhigang [2 ,3 ]
Wu, Yiqi [4 ]
机构
[1] Wuhan Univ, Dept Pathol, Wuhan Hosp 3, Wuhan, Peoples R China
[2] Wuhan Univ, Tongren Hosp, Wuhan, Peoples R China
[3] Wuhan Univ, Burns Dept, Wuhan Hosp 3, Wuhan, Peoples R China
[4] Wuhan Univ, Dept Urol, Renmin Hosp, Wuhan 430060, Peoples R China
关键词
Majolin's ulcer; HER2; p53; VEGF; pathological characteristics; P53; CANCER; EXERTS; VEGF;
D O I
10.1093/jbcr/irad199
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Marjolin's ulcer is described as malignant lesions developed in the injured skin, which can cause several kinds of malignancies. Our results showed that no HER2 but p53 was detected in Majorlin's ulcer samples. Meanwhile, by statistical analysis, we found that the positive rate of p53 in Majorlin's ulcer samples was associated with the pathological type of ulcer canceration and degree of tumor differentiation. The positive expression rate of vascular endothelial growth factor (VEGF) was 62.5% in poorly differentiated squamous cell carcinoma (SCC), 39.4% in moderately differentiated SCC, and 66.7% in well-differentiated SCC, respectively. Furthermore, some cases of Majorlin's ulcer with positive P53 were negative for VEGF, while some cases with positive VEGF were negative for P53. Image superposition showed that VEGF expression was absent or minimal in p53-positive cases. However, P53 was not expressed or rarely expressed in VEGF-positive cases. Our results of this study will suggest that P53 can be used as the mark of Marjolin's ulcer differentiation, and there may be some interaction between P53 and VEGF in Marjolin's ulcer. The regulation of microenvironment in the oncogenesis, progression, and differentiation of Marjolin's ulcer is complex and needs further study.
引用
收藏
页码:719 / 727
页数:9
相关论文
共 31 条
[1]   Activating HER2 mutations as emerging targets in multiple solid cancers [J].
Connell, Claire M. ;
Doherty, Gary J. .
ESMO OPEN, 2017, 2 (05)
[2]   Marjolin's Ulcer: A Preventable Complication of Burns? [J].
Copcu, Eray .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 124 (01) :156E-164E
[3]  
Fan P., 2023, ALLEVIATING HYPOXIA, V26, DOI [10.1038/s41388-023-02869-2, DOI 10.1038/S41388-023-02869-2]
[4]   p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway [J].
Farhang Ghahremani, M. ;
Goossens, S. ;
Nittner, D. ;
Bisteau, X. ;
Bartunkova, S. ;
Zwolinska, A. ;
Hulpiau, P. ;
Haigh, K. ;
Haenebalcke, L. ;
Drogat, B. ;
Jochemsen, A. ;
Roger, P. P. ;
Marine, J-C ;
Haigh, J. J. .
CELL DEATH AND DIFFERENTIATION, 2013, 20 (07) :888-897
[5]   VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells. [J].
T. Fujisawa ;
J. Watanabe ;
Y. Kamata ;
M. Hamano ;
H. Hata ;
H. Kuramoto .
Human Cell, 2003, 16 (1) :47-54
[6]   The Point Prevalence of Malignancy in a Wound Clinic [J].
Ghasemi, Farhad ;
Anooshirvani, Niloofar ;
Sibbald, R. Gary ;
Alavi, Afsaneh .
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2016, 15 (01) :58-62
[7]   NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES [J].
Goel, Shom ;
Duda, Dan G. ;
Xu, Lei ;
Munn, Lance L. ;
Boucher, Yves ;
Fukumura, Dai ;
Jain, Rakesh K. .
PHYSIOLOGICAL REVIEWS, 2011, 91 (03) :1071-1121
[8]   Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain [J].
Haupt, S. ;
Gamell, C. ;
Wolyniec, K. ;
Haupt, Y. .
CELL DEATH AND DIFFERENTIATION, 2013, 20 (07) :852-854
[9]   Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: Relationship to oral risk habits and prognostic factors [J].
Helal, Thanaa El A. ;
Fadel, Mona T. ;
El-Thobbani, Abdalla K. ;
El-Sarhi, Amira M. .
ORAL ONCOLOGY, 2012, 48 (02) :120-124
[10]  
Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI [10.1155/2014/357027, 10.1155/2014/852748]